Neil W. Gibson, Chief Scientific Officer at Regulus Therapeutics Inc. (RGLS), sold 4,200 shares at $8.01 ($34K) on 2014-09-11, disclosed to the SEC on 2014-09-15.
Scheduled sale ($34k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.01 | 2,000 | $16K | 47.6% |
| 2 | $8.01 | 2,200 | $18K | 52.4% |
| Total | $8.01 avg | 4,200 | $34K | 100% |
| Filing → |
| RGLS | SELL | 2014-12-01 | $48K | — | Filing → |
| RGLS | SELL | 2014-10-31 | $48K | — | Filing → |
| RGLS | SELL | 2014-10-24 | $48K | — | Filing → |